litlas
Log inCreate account

David Stirling

Active 1977–2024

Affiliations
Celanese (United States)Bristol-Myers Squibb (Switzerland)BHP (Australia)This corpus build does not record the country of an author's affiliations, so none is shown here. It does not mean these institutions have no country.
ORCID
0000-0003-1219-2794
125
Papers
14,331
Citations
59
h-index
87
i10-index

Self-citations are included in these numbers.

Citations per year

Citations

Citations per year for David Stirling1977: 1 citations1978: 2 citations1979: 7 citations1980: 9 citations1981: 4 citations1982: 7 citations1983: 8 citations1984: 6 citations1985: 10 citations1986: 17 citations1987: 5 citations1988: 10 citations1989: 10 citations1990: 12 citations1991: 14 citations1992: 12 citations1993: 9 citations1994: 12 citations1995: 7 citations1996: 12 citations1997: 18 citations1998: 16 citations1999: 46 citations2000: 20 citations2001: 50 citations2002: 108 citations2003: 110 citations2004: 112 citations2005: 130 citations2006: 113 citations2007: 134 citations2008: 143 citations2009: 138 citations2010: 112 citations2011: 153 citations2012: 124 citations2013: 133 citations2014: 110 citations2015: 93 citations2016: 80 citations2017: 101 citations2018: 116 citations2019: 261 citations2020: 311 citations2021: 288 citations2022: 198 citations2023: 140 citations2024: 171 citations2025: 87 citations2026: 3 citations
  • 2 years (2 citations) are not shown (dated before this author's first paper)

Citation sources

Countries

This corpus build does not record which country the citing authors are in, so the country breakdown is not computed. The other breakdowns below are unaffected.

Institutions

Fields

  • Medicine39.4%
  • Biochemistry, Genetics and Molecular Biology18.1%
  • Engineering9.9%
  • Environmental Science7.1%
  • Immunology and Microbiology6.1%
  • Computer Science6%
  • Other13.4%

Topics

  • Multiple Myeloma Research and Treatments25.3%
  • Protein Degradation and Inhibitors11.9%
  • Microbial metabolism and enzyme function8.3%
  • Immune Cell Function and Interaction6.6%
  • Nanoparticle-Based Drug Delivery5.4%
  • CAR-T cell therapy research5.2%
  • Other37.2%

Frequent coauthors

All papers

Open in search

Loading papers…